MedPath

Effect of curcumin supplementation in patients with lupus

Phase 3
Conditions
Systemic lupus erythematosus.
Systemic lupus erythematosus (SLE)
M32.9
Registration Number
IRCT20210425051077N1
Lead Sponsor
Vice Chancellor for Research of Khalkhal University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
66
Inclusion Criteria

Not using any nutritional supplements within 2 months before the beginning of the study except calcium-vitamin D supplement
No history of gallstones
Not following a special diet
Not using anticoagulant drugs
Not having Coronavirus Disease
Age between 18 and 60 years old

Exclusion Criteria

Pregnancy and lactation
Change in type and dose of drugs
Following a special diet during the study
Starting to take any dietary supplements during the study
Having Coronavirus Disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath